Haemagglutinin-strain A(H1N1)

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Brand Names
Afluria Tetra, Agriflu, FluLaval Tetra, Fluad, Fluad Pediatric, Fluviral, Fluzone, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent, Influvac Tetra
Generic Name
Haemagglutinin-strain A(H1N1)
DrugBank Accession Number
DB15476
Background

Not Available

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Inactivated
Synonyms
  • Haemagglutinin-strain A (H1N1)

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
PanenzaSuspension15 mcg / 0.5 mLIntramuscularSanofi Pasteur Inc.Not applicableNot applicableCanada flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ADIMFLUHaemagglutinin-strain A(H1N1) (15 mcg/0.5ml) + Haemagglutinin-strain A(H3N2) (15 mcg/0.5ml) + Influenza virus type B (Victoria) (15 mcg/0.5ml)บริษัท ไบโอเนท - เอเชีย จำกัด จำกัด2019-09-09Not applicableThailand flag
Afluria TetraHaemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus S.R.L.2020-09-23Not applicableCanada flag
Afluria TetraHaemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL)SuspensionIntramuscularSeqirus S.R.L.2019-10-25Not applicableCanada flag
Afluria Tetra Injektionssuspension in einer FertigspritzeHaemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain B (Victoria-like) (15 mcg) + Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (formaldehyde inactivated) (15 mcg)Injection, suspensionIntramuscularSeqirus S.R.L.2020-05-26Not applicableAustria flag
AgrifluHaemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain B (15 mcg)SuspensionIntramuscularSeqirus S.R.L.2010-10-042020-06-30Canada flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available

References

General References
Not Available
Not Available

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
Not AvailableCompletedNot AvailableAstrocytoma / Glioma / Oligodendroglioma1somestatusstop reasonjust information to hide
Not AvailableCompletedNot AvailableInflammation / Iron Deficiency Anemia (IDA)1somestatusstop reasonjust information to hide
Not AvailableCompletedBasic ScienceAcquired Immune Deficiency Syndrome (AIDS) / Flu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections1somestatusstop reasonjust information to hide
Not AvailableCompletedPreventionFlu caused by Influenza2somestatusstop reasonjust information to hide
Not AvailableCompletedPreventionHeart Failure / Mamma Carcinoma1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, suspensionIntramuscular
SuspensionIntramuscular
SuspensionIntramuscular; Subcutaneous
Injection, suspensionIntramuscular; Subcutaneous
SuspensionIntradermal
SuspensionIntramuscular15 mcg / 0.5 mL
Injection
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at August 30, 2019 15:26 / Updated at November 30, 2021 07:50